[Code of Federal Regulations]
[Title 28, Volume 2]
[Revised as of July 1, 2003]
From the U.S. Government Printing Office via GPO Access
[CITE: 28CFR79.21]

[Page 340-341]
 
                    TITLE 28--JUDICIAL ADMINISTRATION
 
              CHAPTER I--DEPARTMENT OF JUSTICE (Continued)
 
PART 79--CLAIMS UNDER THE RADIATION EXPOSURE COMPENSATION ACT--Table of Contents
 
Subpart C--Eligibility Criteria for Claims Relating to Certain Specified 
                      Diseases in an Affected Area
 
Sec. 79.21  Definitions.

    (a) The definitions listed in Sec. 79.11 (a) through (e) and (i) 
apply to this subpart.
    (b) Indication of disease means any medically significant 
information that suggests the presence of a disease, whether or not the 
presence of the disease is later confirmed.
    (c) Leukemia, lung cancer, in situ lung cancer, multiple myeloma, 
lymphomas, Hodgkin's disease, primary cancer of the thyroid, primary 
cancer of the male breast, primary cancer of the female breast, primary 
cancer of the esophagus, primary cancer of the stomach, primary cancer 
of the pharynx, primary cancer of

[[Page 341]]

the small intestine, primary cancer of the pancreas, primary cancer of 
the bile ducts, primary cancer of the gallbladder, primary cancer of the 
salivary gland, primary cancer of the urinary bladder, primary cancer of 
the brain, primary cancer of the colon, primary cancer of the ovary, and 
primary cancer of the liver mean the physiological conditions that are 
recognized by the National Cancer Institute under those names or 
nomenclature, or under any previously accepted or commonly used names or 
nomenclature.
    (d) Lung cancer means any physiological condition of the lung, 
trachea, or bronchus that is recognized under that name or nomenclature 
by the National Cancer Institute.
    (e) Specified compensable diseases means leukemia (other than 
chronic lymphocytic leukemia), provided that initial exposure occurred 
after the age of 20 and that the onset of the disease was at least two 
years after first exposure, lung cancer (other than in situ lung cancer 
that is discovered during or after a postmortem exam), and the following 
diseases, provided onset was at least five years after first exposure: 
multiple myeloma; lymphomas (other than Hodgkin's disease); and primary 
cancer of the thyroid, male or female breast, esophagus, stomach, 
pharynx, small intestine, pancreas, bile ducts, gallbladder, salivary 
gland, urinary bladder, brain, colon, ovary, or liver (except if 
cirrhosis or hepatitis B is indicated).